Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome.
about
Beta-3 adrenergic receptor agonist for adult with overactive bladderDrug therapy of overactive bladder--what is coming next?Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence.A current perspective on geriatric lower urinary tract dysfunction.β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinaseHow β3 -adrenoceptor-selective is mirabegron?New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA.Overactive bladder - 18 years - Part IIOn the Site and Mechanism of Action of β3-Adrenoceptor Agonists in the BladderMirabegron in overactive bladder: a review of efficacy, safety, and tolerability.Bladder function of patients with Parkinson's disease.Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline?Solabegron: a potential future addition to the β-3 adrenoceptor agonist armamentarium for the management of overactive bladder.Delivery methods for drugs used in the treatment of overactive bladder.Safety and tolerability of β3-adrenoceptor agonists in the treatment of overactive bladder syndrome - insight from transcriptosome and experimental studies.Mirabegron.Editorial comment to urinary incontinence in patients with Alzheimer's disease: relationship between symptom status and urodynamic diagnoses.A door opener for future research: agonist-induced β3-adrenoceptor desensitization in HEK cells but not CHO cells.Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management.Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder.
P2860
Q24187596-23E33176-D0C1-4F93-9F00-FDDCD95B1242Q26780197-2F96D39B-81CD-4E65-A059-CADDDEA7E6D1Q34405906-49682D79-E5D4-43B0-9502-EE9E4AC30F41Q35348864-DEB8F036-DB5A-4C72-8592-A3AD3977BB21Q35762174-A0C3E72E-FA45-4CCF-AC80-C097793D8A8DQ36506885-A8FA3365-D23E-4D95-979F-8A49C64664CAQ36789948-8A9CA8DA-928E-4E4F-AB0B-946A980CBC40Q36912766-C38E75BE-4753-4789-9793-D0CCD13A3202Q37737698-C91B17F1-4D38-41F0-897D-3EC5E78E7B06Q38152756-E861A718-5084-482A-AA96-4982CA9C0C6AQ38191267-EDBCB849-167C-4CE0-8922-669036E84D25Q38265873-8808DA59-18CF-4433-94AB-780E4054C357Q38306806-B9A5D11B-F934-4FC3-98DA-0D137363ABCBQ38665319-62F96327-0849-471B-B0E2-5C63BFA28C6EQ38765381-D2AE7E8E-10CA-4F5F-803C-5CABAB600DE5Q41266128-127CD61C-B50A-45A9-98C5-91CDBDAB7F71Q44674136-299D94A9-1D94-4FAB-86A8-BDEEBC02B291Q44910331-5C18460C-63B5-4DBE-966D-C74C384529DCQ45912105-6124170C-C7FE-4BA2-A0DF-A05E1028B0DCQ47880195-0C97C72E-1718-488D-B09C-18A533BD8E00Q47976147-C7D51802-6365-419C-B9C9-FE874E49EBF3Q53630970-1257600A-04EB-4A24-9154-7CB27281B7BF
P2860
Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Pharmacological profile of β3- ...... f overactive bladder syndrome.
@en
Pharmacological profile of β3- ...... f overactive bladder syndrome.
@nl
type
label
Pharmacological profile of β3- ...... f overactive bladder syndrome.
@en
Pharmacological profile of β3- ...... f overactive bladder syndrome.
@nl
prefLabel
Pharmacological profile of β3- ...... f overactive bladder syndrome.
@en
Pharmacological profile of β3- ...... f overactive bladder syndrome.
@nl
P1476
Pharmacological profile of β3- ...... f overactive bladder syndrome.
@en
P2093
Yasuhiko Igawa
P2888
P304
P356
10.1007/S00210-012-0824-1
P577
2012-12-21T00:00:00Z
P5875
P6179
1006354071